Kerre T C, De Smet G, De Smedt M, Offner F, De Bosscher J, Plum J, Vandekerckhove B
Department of Clinical Chemistry, Microbiology, and Immunology, Ghent University Hospital, 4BlokA, De Pintelaan 185, B-9000 Ghent, Belgium.
J Immunol. 2001 Oct 1;167(7):3692-8. doi: 10.4049/jimmunol.167.7.3692.
Human hemopoietic stem cells (HSC) have been shown to engraft, differentiate, and proliferate in the hemopoietic tissues of sublethally irradiated NOD/LtSZ scid/scid (NOD/SCID) mice. We used this model to study homing, survival, and expansion of human HSC populations from different sources or phenotype. We observed that CD34+ cells homed specifically to bone marrow (BM) and spleen, but by 3 days after injection, survived only in the BM. These BM-homed CD34+ cells proliferated intensively and gave rise to a 12-fold, 5.5-fold, and 4-fold expansion in 3 days for umbilical cord blood, adult mobilized peripheral blood, and adult BM-derived cells, respectively. By injection of purified subpopulations, it was demonstrated that both CD34+38+ and CD34+38- umbilical cord blood HSC homed to the BM and expanded. Importantly, kinetics of expansion were different: CD34+38+ cells started to increase in cell number from day 3 onwards, and by 4 wk after injection, virtually all CD34+ cells had disappeared. In contrast, CD34+38- cells remained quiescent during the first week and started to expand intensively from the third week on. In this paper, we have shown that homing, survival, and expansion of stem cells are three independent phenomena important in the early phase of BM engraftment and that kinetics of engraftment differ between CD34+38+ and CD34+38- cells.
已证明人类造血干细胞(HSC)可在亚致死剂量照射的NOD/LtSZ scid/scid(NOD/SCID)小鼠的造血组织中植入、分化和增殖。我们利用该模型研究来自不同来源或表型的人类HSC群体的归巢、存活和扩增情况。我们观察到CD34+细胞特异性归巢至骨髓(BM)和脾脏,但在注射后3天,仅在骨髓中存活。这些归巢至骨髓的CD34+细胞大量增殖,脐血、成人动员外周血和成人骨髓来源的细胞在3天内分别扩增了12倍、5.5倍和4倍。通过注射纯化的亚群,证明CD34+38+和CD34+38-脐血HSC均归巢至骨髓并扩增。重要的是,扩增动力学不同:CD34+38+细胞从第3天开始细胞数量增加,注射后4周时,几乎所有CD34+细胞都消失了。相比之下,CD34+38-细胞在第一周保持静止,从第三周开始大量扩增。在本文中,我们表明干细胞的归巢、存活和扩增是骨髓植入早期重要的三个独立现象,并且CD34+38+和CD34+38-细胞之间的植入动力学不同。